1 completed, 1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Lower-risk Myelodysplastic Syndromes: new trials by email Literature Review of Lower-risk Myelodysplastic Syndromes trials Research Report on Lower-risk Myelodysplastic Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia rhTPO, Cyclosporine (CsA) - Lower-risk Myelodysplastic Syndromes | Phase 3 | Not yet recruiting | Peking Union Medical College Hospital | 78 | 2026-06-01 | 2026-06-17 |
| Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan Red blood cell transfusion - Lower-risk Myelodysplastic Syndromes | Completed | Bristol-Myers Squibb | 177 | 2023-12-22 | 2025-12-04 |
Cyclosporine (1) · Erythrocyte Transfusion (1)
Bristol-Myers Squibb (1) · Peking Union Medical College Hospital (1)
Japan (1)